港股异动 | 中资券商股普跌 多家券商半年报遭问询 关注股票质押业务风险
格隆汇9月17日丨中资券商股普跌,国联证券(1456.HK)跌5.22%领跌,中国银河(6881.HK)、光大证券(6178.HK)和东方证券(3958.HK)均跌超4%。今年以来,随着部分企业、实际控制人现金流压力凸显,不少券商股票质押业务出现违约,诉讼迭起。该项信用业务的整体风险和个体风险均受到了市场关注。在今年中期报告披露后,9月初到现在,已有多家上市券商接到交易所问询函,其中密集提到了该业务的计提问题。交易所重点关注券商股票质押相关业务的开展、风险管控等情况以及相关减值计提的充分性和合理性。买入返售金融资产计提减值准备是交易所普遍关切的问题,而该数据背后则是对股票质押业务风险的梳理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.